Yaso Therapeutics, Inc. is a startup, clinical stage pharmaceutical company which holds the worldwide license to a novel polyanionic drug, PPCM.  Yaso is developing a variety of drug products containing PPCM for topical delivery.

Family planning for women at every stage of their lives.

Innovative antiviral solutions for treatment and prevention of HSV1 and HSV2.

Our patented drug, PPCM, has broad activity against viruses and other pathogens.

Women need non-hormonal contraceptives that are effective, safe, affordable and accessible. Yaso delivers that, and more.